Delivery Order SPE2DB20D2002-SPE2DB24FL86Y

Award Date 9/12/24
Potential Completion Date 9/13/24
Potential Value $6.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of 4,566,122,144 units of Methylphenidate ER 36 mg tablets in 100-count bottles. The firm-fixed-price delivery order, valued at $1,183.58, has an ultimate completion date of October 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,093.91 firm-fixed-price delivery order is for the supply of 4,563,429,509 units of Methylphenidate ER 36 mg tablets. The contract has an ultimate completion date of January 25, 2024 and was awarded on January 24, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,961.33 firm fixed-price delivery order is for the supply of 100 units of Methylphenidate ER 36 mg tablets. The contract has an ultimate completion date of March 14, 2025 and is not designated with a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award from the Defense Logistics Agency (DLA) is to Amerisourcebergen Drug Corporation's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $2,513.65 firm fixed price delivery order is for the supply of 4,564,541,466 methylphenidate ER 18 mg tablets, with a period of performance through May 9, 2024. Amerisourcebergen holds a $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,319.97 firm fixed-price delivery order is for the supply of 4,567,193,190 units of Methylphenidate ER 18 mg tablets. The contract has an ultimate completion date of February 6, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,414.34, is a delivery order for the provision of 4,566,477,023 tablets of Methylphenidate ER 36 mg. The contract has an ultimate completion date of November 19, 2024. It is a firm fixed-price contract with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,973.30 Firm Fixed Price Delivery Order covers the supply of 4,566,121,547 units of the pharmaceutical product Methylphenidate ER 36 mg Tablets in 100-count bottles. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,174.71 firm fixed-price delivery order is for the supply of METHYLPHENIDATE ER 36 MG TAB 100S, a prescription medication. The contract has an ultimate completion date of November 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,502,453 units of methylphenidate ER 18 mg tablets in 100-count bottles. The $1,519.44 firm fixed-price Delivery Order (DO) has a completion date of November 21, 2024 and is not subject to any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,396.14, is for the delivery of Methylphenidate ER 36 mg tablets in 100-count bottles. This is a firm fixed-price delivery order contract with a completion date of November 16, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB20D2002
    Indefinite Delivery Contract
  • SPE2DB20D2002-SPE2DB24FL86Y
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,794.49 firm fixed-price delivery order is for the supply of 4,565,796,242 units of Methylphenidate ER 36 mg tablets, which will be delivered by September 13, 2024.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

The contract award reviewed has no set-aside designation, indicating open competition. This delivery order is a component of AmerisourceBergen's broader federal contracting portfolio, which includes numerous awards from the DLA and other agencies for a wide range of pharmaceutical and medical commodities across various therapeutic areas.

Generated 2/27/25, 10:15 AM